Quest Diagnostics (DGX) Reports In-Line Q3 EPS, Revenues Miss; Lowers FY18 EPS/Reveunes Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Quest Diagnostics (DGX) PT Lowered to $121 at Credit Suisse
October 24, 2018 8:47 AM EDTCredit Suisse analyst A.J. Rice lowered the price target on Quest Diagnostics (NYSE: DGX) to $121.00 (from $128.00) while maintaining an Outperform rating following results.
Rice said Long-term Tailwinds Still in Play, Despite a Short-term Speed Bump.
... MoreQuest Diagnostics (DGX) Reports Acquisition of Hurley Medical Center's Outreach Laboratory Services Operation in Central Michigan
October 22, 2018 9:32 AM EDT3 Quest Diagnostics (NYSE: DGX) today announced it has acquired certain assets of the outreach laboratory services operation of Hurley Medical Center, a leading regional provider of healthcare services.
Patients and providers in central Michigan will have access to Quest's broader range of diagnostic services, a... More
BofA/Merrill Lynch Reinstates Quest Diagnostics (DGX) at Buy
October 19, 2018 6:09 AM EDTBofA/Merrill Lynch analyst Derik de Bruin reinstates coverage on Quest Diagnostics (NYSE: DGX) with a Buy rating and a price target of $116.00.
For an analyst ratings summary and ratings history on Quest Diagnostics... More
